Plunkett Research Online: PhaseRx

PHASERX (PZRXQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

PhaseRx Inc is a biopharmaceutical company. It is developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy, or i-ERT. The approach is enabled by proprietary Hybrid messenger RNA, or mRNA, Technology platform, wh.....


PHASERX

Ticker: PZRXQ
Exchange: OTCM
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 206 805-6300
Fax:
Address: 410 West Harrison Street
Seattle, WA 98119 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Gordon BrandtChief Medical Officer
Paul JohnsonDirector
See More
PhaseRx Inc is a biopharmaceutical company. It is developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy, or i-ERT. The approach is enabled by proprietary Hybrid messenger RNA, or mRNA, Technology platform, wh.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture